*NEW protocol template document below. Call the IRB office at 617-636-7512 if you have any questions.
Every prospective human subjects research study must have a protocol. When a study is sponsored by industry, a protocol is typically provided by the sponsor. If a protocol is not provided by the sponsor, or a study is initiated by the Principal Investigator (PI), the PI must create a detailed protocol for the study. If a protocol does not accompany the submission to the IRB, it will delay the review of the research.
To assist with the creation of a protocol, the IRB office has provided the following protocol templates:
NIH and FDA Clinical e-Protocol Writing Tool – This is an electronic protocol building tool created by the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) for phase 2 and 3 IND/IDE studies..
Form 7 (Record/Database/Specimen Review) – Required for retrospective medical record/chart/electronic database/specimen review and databases created for research purposes. When submitting a Form 7, there is no need to submit a separate protocol (and no need to submit a Form 1). For 7 will serve as the protocol for these studies.
This website provides recommendation of scientific, ethical, and administrative elements that should be addressed in a clinical trial protocol. Included are a useful checklist (WORD | PDF) and example table of assessments (WORD | PDF).